Sort
78,016 grants matching “breast cancer”
Cohort Follow-up and Database Maintenance
$1,156,771Eric B Rimm · Harvard School Of Public Health · P01 · FY2008 · CA
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy
$1,156,734Amanda M Schalk · Enzyme By Design, Inc. · R44 · FY2020 · CA
Cohort Analytics Core
$1,156,714Joshua Denny · National Human Genome Research Institute · ZIC · FY2024 · HG
Nuclear Structure and Gene Expression
$1,155,716Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2008 · CA
Nuclear Structure and Gene Expression
$1,155,498Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2015 · CA
Baptist Memorial Health Care/Mid South NCORP Minority Underserved Consortium
$1,155,224Raymond U Osarogiagbon · Baptist Memorial Hospital - Tipton · UG1 · FY2023 · CA
Evaluation of an implantable microdevice for rapid cancer drug screening directly in T cell lymphoma patients
$1,155,118Cecilia Larocca · Brigham And Women'S Hospital · R37 · FY2025 · CA
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORT
$1,155,061Brigham And Women'S Hospital · R01 · FY2001 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$1,155,055Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Cancer Biology and Genetics
$1,155,009Harold Varmus · National Human Genome Research Institute · ZIA · FY2015 · HG
VIPCare: Virtual Predictive Care workflow with EHR integrated surveillance for optimalfollow-up care management for Cancer Patients
$1,154,996Sugato Bagchi · Vizlitics Inc. · R44 · FY2025 · CA
Sioux Community Cancer Consortium
$1,154,716Sanford Clinic · U10 · FY2004 · CA
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models
$1,154,104Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Center of Excellence for Cancer Research, Training and Community Service
$1,153,912Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · P20 · FY2012 · MD
CANCER CENTER SUPPORT GRANT (CCSG)
$1,153,772University Of Vermont &St Agric College · P30 · FY2001 · CA
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
$1,153,705Miriam C Poirier · Basic Sciences · Z01 · FY2007 · CA
Deep South Network for Cancer Control
$1,153,103Edward E Partridge · University Of Alabama At Birmingham · U54 · FY2013 · CA
Cellular Mechanisms Of Xenobiotic Transport
$1,153,051David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
A Novel Immunotherapy Targeting Cancer Stem Cells for the Treatment of Triple-Negative Breast Cancer
$1,152,921Joseph Patti · Agilvax, Inc. · R44 · FY2020 · CA
Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk
$1,152,838Bing Li · University Of Iowa · U01 · FY2023 · CA
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)
$1,152,820Christopher I Li · Fred Hutchinson Cancer Research Center · U24 · FY2019 · CA
TeleHealth Resistance exercise Intervention to preserve dose intensity and Vitality in Elder breast cancer patients (THRIVE)
$1,152,637Kathryn H. Schmitz · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · CA
Cancer Risk in Human Populations
$1,152,632Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
TGF-betas in breast cancer progression
$1,152,383Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
POLYCYCLIC AROMATIC HYDROCARBONS (PAHS) AND BREAST CANCER RISK
$1,152,318The Trustees Of Columbia University In The City Of New York · · FY2020 · Defense Health Agency